Susan H. Guttentag, MD
The Medical College of Pennsylvania, Philadelphia, PA, 1985
Pediatric Residency-Wilford Hall USAF Medical Center, Lackland AFB,Texas
Neonatal-Perinatal Medicine Fellowship-The Childrens Hospital of Boston, Harvard Medical School, Boston, MA
Lung development, the impact of preterm birth on lung development, pulmonary surfactant, genetic lung diseases, chronic lung disease associated with prematurity (bronchopulmonary dysplasia)
As a research fellow many years ago, Dr. Guttentag had the opportunity to investigate lung surfactant biology just as surfactant therapy was approved for use in prematurely born infants with lung immaturity. This great advance in neonatology from the 20th century fueled her passion for translating basic science discoveries into solutions for human lung disease. At Vanderbilt, Dr. Guttentag's laboratory research now focuses on mechanisms of lung injury and effective repair, as exemplified by a rare genetic disorder — Hermansky Pudlak syndrome. Rare diseases provide unique insight into more common diseases, and the explosion of human genomics, basic biology and mouse modeling holds great potential to bring new life-saving and disease-mitigating therapies for human lung diseases.